UK markets close in 4 hours 19 minutes

Deep Medicine Acquisition Corp. (DMAQ)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.98+0.01 (+0.15%)
At close: 09:36AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 164.00M
Enterprise value 163.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.32
Enterprise value/revenue N/A
Enterprise value/EBITDA -399.17

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 31.32%
S&P500 52-week change 3-12.23%
52-week high 310.99
52-week low 39.70
50-day moving average 39.99
200-day moving average 39.93

Share statistics

Avg vol (3-month) 317.04k
Avg vol (10-day) 31.29k
Shares outstanding 513.27M
Implied shares outstanding 6N/A
Float 811.63M
% held by insiders 14.79%
% held by institutions 197.23%
Shares short (14 Jun 2022) 411.73k
Short ratio (14 Jun 2022) 40.7
Short % of float (14 Jun 2022) 40.10%
Short % of shares outstanding (14 Jun 2022) 40.07%
Shares short (prior month 12 May 2022) 415.88k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2022
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-0.40%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-414.05k
Diluted EPS (ttm)-0.03
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)877.1k
Total cash per share (mrq)0.05
Total debt (mrq)500k
Total debt/equity (mrq)N/A
Current ratio (mrq)240.26
Book value per share (mrq)-0.23

Cash flow statement

Operating cash flow (ttm)-697.87k
Levered free cash flow (ttm)-128.3M